🇪🇺 Faslodex in European Union

EMA authorised Faslodex on 10 March 2004

Marketing authorisation

EMA — authorised 10 March 2004

  • Status: approved

Faslodex in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Faslodex approved in European Union?

Yes. EMA authorised it on 10 March 2004.

Who is the marketing authorisation holder for Faslodex in European Union?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.